City
Epaper

Covid-19 cured exceed new cases in Tamil Nadu on Thursday

By IANS | Published: September 03, 2020 7:31 PM

Chennai, Sep 3 The number of persons cured of Covid-19 in Tamil Nadu on Thursday, at 6,110, was ...

Open in App

Chennai, Sep 3 The number of persons cured of Covid-19 in Tamil Nadu on Thursday, at 6,110, was higher than the 5,892 persons who tested positive for the disease over the past 24 hours, the state Health Department said.

In a statement issued here, the department said a total of 6,110 persons were cured of Covid-19 and were discharged from various hospitals, taking the tally to 386,173, while 5,892 persons tested positive over the past 24 hours, taking the total tally to 445,851.

The state recorded the death of 92 Covid-19 patients, taking its toll to 7,608.

The total number of active Covid-19 cases stands at 52,070.

State capital Chennai continued to head the Covid-19 infection table with 968 persons testing positive for the virus and the total tally standing at 138,724.

The number of infected children in the state in the age group 0-12 went up to 20,322.

( With inputs from IANS )

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: State Health Department
Open in App

Related Stories

PoliticsGujarat govt doubles healthcare benefits for Ayushman Card holders

National15-year-old boy in Kerala dies of PAM, a rare brain infection

PoliticsZero Covid cases reported in Goa in last two days

HealthTN Health Dept to organise 100 medical camps on June 24

NationalRestoration of essential services underway in cyclone-hit Kutch

Health Realted Stories

HealthStudy shows rotavirus vaccinations safe for babies in NICU

HealthKnow Why Chia Seeds Are a Powerful Addition to Your Diet

HealthTB claimed 108 lives in Mizoram in 2023

HealthReducing air pollution key to fight new diabetes cases in India: Doctors

NationalCovaxin-Developer Bharat Biotech Amid Reports on AstraZeneca Vaccine, Says ‘Safety Is Primary Focus for All Our Vaccines’